Canada markets close in 3 hours 44 minutes

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9350+0.0150 (+0.78%)
As of 12:08PM EDT. Market open.
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
93,790
93,790
61,464
42,794
13,286
Selling General and Administrative
33,304
33,304
32,552
21,228
6,709
Total Operating Expenses
126,937
126,937
88,855
55,187
18,674
Operating Income or Loss
-126,937
-126,937
-88,855
-55,187
-18,674
Interest Expense
-
-
-
3
367
Total Other Income/Expenses Net
9,265
9,265
-6,784
334
-1,038
Income Before Tax
-117,672
-117,672
-95,639
-54,853
-19,955
Income from Continuing Operations
-117,672
-117,672
-95,639
-54,853
-19,955
Net Income
-117,672
-117,672
-95,639
-54,853
-19,955
Net Income available to common shareholders
-117,672
-117,672
-95,639
-55,274
-19,955
Basic EPS
-3.17
-
-2.53
-1.49
-1.67
Diluted EPS
-3.17
-
-2.53
-1.49
-1.67
Basic Average Shares
37,958
-
37,733
36,921
11,967
Diluted Average Shares
37,958
-
37,733
36,921
11,967